Literature DB >> 25329128

Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw.

Octavian Dincă1, Sabina Zurac, Florica Stăniceanu, Mihai Bogdan Bucur, Dana Cristina Bodnar, Cristian Vlădan, Alexandru Bucur.   

Abstract

The authors report their experience using platelet-rich fibrin (PRF) therapy for the treatment of ten patients presenting bisphosphonate-related osteonecrosis of the jaw (BRONJ). The aim of our study was to evaluate the effect of this therapy on recurrent BRONJ and to describe the clinical and histopathological/immunohistochemical staining features of PRF treatment. As such, we describe the method we used and report the results observed in the areas treated as well as side effects. The reported results recommend the safety and efficacy of PRF in treatment of BRONJ.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25329128

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN： 1220-0522            Impact factor:   1.033


  6 in total

1.  Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam.

Authors:  Anton Straub; Andreas Vollmer; Thiên-Trí Lâm; Roman C Brands; Maximilian Stapf; Oliver Scherf-Clavel; Max Bittrich; Andreas Fuchs; Alexander C Kübler; Stefan Hartmann
Journal:  Clin Oral Investig       Date:  2022-08-09       Impact factor: 3.606

2.  The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.

Authors:  Olga Di Fede; Federica Canepa; Vera Panzarella; Rodolfo Mauceri; Carmine Del Gaizo; Alberto Bedogni; Vittorio Fusco; Pietro Tozzo; Giuseppe Pizzo; Giuseppina Campisi; Antonio Galvano
Journal:  Int J Environ Res Public Health       Date:  2021-08-10       Impact factor: 3.390

Review 3.  The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ).

Authors:  Jorge A Cano-Durán; Juan-Francisco Peña-Cardelles; Daniel Ortega-Concepción; Víctor M Paredes-Rodríguez; Mariano García-Riart; Juan López-Quiles
Journal:  J Clin Exp Dent       Date:  2017-08-01

Review 4.  Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review.

Authors:  Rokas Gelazius; Lukas Poskevicius; Dalius Sakavicius; Vaidas Grimuta; Gintaras Juodzbalys
Journal:  J Oral Maxillofac Res       Date:  2018-09-30

5.  Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series.

Authors:  Guillermo Pardo-Zamora; Yanet Martínez; Jose Antonio Moreno; Antonio J Ortiz-Ruíz
Journal:  Int J Environ Res Public Health       Date:  2021-01-24       Impact factor: 3.390

6.  Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases.

Authors:  Yuka Kojima; Sakiko Soutome; Mitsunobu Otsuru; Saki Hayashida; Yuki Sakamoto; Shunsuke Sawada; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-26       Impact factor: 4.614
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.